Insulin-free Cow Milk Formula in Prevention of Type 1 Diabetes Associated Autoimmunity - FINDIA Pilot Study — FINDIA  

Beta-cell Autoimmunity Clinical Trial

Official title: Pilot Study of Dietary Prevention of Type 1 Diabetes Associated Beta-cell Autoimmunity in Children at Genetic Risk

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether weaning to whey-based hydrolysed formula or essentially bovine insulin free whey-based FINDIA formula instead of standard cow's milk based formula is effective in the prevention of type 1 diabetes associated beta-cell autoimmunity in children at genetic risk of type 1 diabetes.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Autoimmune Diseases
• Beta-cell Autoimmunity
• Diabetes Mellitus, Type 1

• NCT number: NCT01055080
• Study type: Interventional
• Source: National Institute for Health and Welfare, Finland
• Status: Completed
• Phase: N/A
• Start date: May 2002
• Completion date: December 2009